Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Capstone Therapeutics Corp (CAPS)

Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Capstone Announces Investor FAQ Focused on 2026 Guidance and Earnings

Company invites shareholder submissions; FAQ to expand on growth trajectory, margin profile, and path to profitability

CAPS : 0.3958 (-3.27%)
Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4x EBITDA Growth in 2026

FY2025 gross margin expands to 23% on $46.9M revenue; FY2026 guidance calls for $72.1M of revenue, ~$18.7M of gross profit (+73%), and a positive EBITDA run-rate starting in Q2

CAPS : 0.3958 (-3.27%)
Capstone Awarded Eldorado Stone Distribution, Targeting $5 Million in Organic Revenue Growth

$5 million in organic revenue sold through existing distribution channels with no incremental investment; share-of-wallet capture from existing customers accelerates near-term revenue ramp

CAPS : 0.3958 (-3.27%)
Capstone Expands Commercial Market Reach with KLAD Integration, Unlocking High-Margin, Asset-Light Revenue Growth

The integration of KLAD Envelope Solutions enables direct access to commercial architects and designers, driving high-margin sales mix and proprietary product pull-through; accelerates path to Q2 EBITDA...

CAPS : 0.3958 (-3.27%)
Capstone Captures Platform Synergies and Accelerates Path to Positive EBITDA as Revenue Momentum Builds

Midwest consolidation delivers $0.5 million in annualized savings as part of the Company’s $2 million cost rationalization program; over 300,000 square feet of new project demand reinforces growth trajectory...

CAPS : 0.3958 (-3.27%)
Capstone Expands Retail Portfolio as Order Volume Accelerates; Contractor Demand Drives Repeat Revenue and EBITDA Growth

New outdoor living product debuts to strong contractor demand at industry trade shows; recent project wins add immediate cash-generative revenue to the platform

CAPS : 0.3958 (-3.27%)
Capstone Therapeutics Strengthens Balance Sheet with Debt Exchange

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Capstone...

CAPS : 0.3958 (-3.27%)
Capstone Targets Growth in Southeast, Identifies Key Acquisition Candidates

Management has identified 1500+ targets to bolster operations

CAPS : 0.3958 (-3.27%)
Cautious Optimism for Building Products Distribution Rising as Sustained Demand for New Residential Construction Expected

EQNX::TICKER_START (NASDAQ:CAPS),(NYSE:QXO),(NYSE:CX),(NYSE:MAS),(NYSE:TTAM) EQNX::TICKER_END

CX : 11.93 (-0.58%)
QXO : 23.83 (-1.61%)
TTAM : 16.81 (+0.48%)
CAPS : 0.3958 (-3.27%)
MAS : 67.14 (+0.69%)
Cautious Optimism for Building Products Distribution Rising as Sustained Demand for New Residential Construction Expected

CX : 11.93 (-0.58%)
QXO : 23.83 (-1.61%)
TTAM : 16.81 (+0.48%)
MAS : 67.14 (+0.69%)
CAPS : 0.3958 (-3.27%)

Barchart Exclusives

Jazz Pharmaceuticals Stock, a Barchart Favorite, Trends Higher as Trump Renews Cannabis Hopes. Should You Buy JAZZ Here?
Jazz Pharmaceuticals stock pops as President Trump signals renewed urgency to reclassify cannabis as Schedule III drug. Technicals signal further upside ahead in JAZZ shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.